PT  - JOURNAL ARTICLE
AU  - Ali M. Sonbaa
AU  - Alaa F. Khayat
AU  - Mohammed A. Almekhlafi
TI  - Safety of tissue plasminogen activator factor in an acute stroke patient with two unruptured cerebral aneurysms
AID  - 10.17712/nsj.2018.4.20180054
DP  - 2018 Oct 01
TA  - Neurosciences Journal
PG  - 334--337
VI  - 23
IP  - 4
4099  - http://nsj.org.sa/content/23/4/334.short
4100  - http://nsj.org.sa/content/23/4/334.full
SO  - Neurosciences (Riyadh)2018 Oct 01; 23
AB  - It is estimated that 6.6%-9.3% of stroke patients have unruptured cerebral aneurysms. The safety of recombinant tissue plasminogen activator (r-tPA) for stroke patients with these aneurysms is uncertain. We report the case of a 58-year old male presented with an acute ischemic stroke within 2 hours of symptom onset and was treated with r-tPA. Further investigation showed that the patient had 2 unruptured cerebral aneurysms. He recovered completely from the stroke and was discharged home in a few days with no deficits. Although cerebral aneurysms are considered a relative contraindication for r-tPA, our case provides evidence that it can be safely administered to these patients.